LuSeed Vascular Overview
LuSeed Vascular is a pioneering medical technology startup that focuses on advancing neurovascular innovation. LuSeed’s ARC is a first-in-class, minimally invasive device for treating both Bifurcation and Sidewall brain aneurysms simply and safely. The device is designed for full compatibility with robotic systems. Its mission is to provide a standard method of care, easily implemented by neuro radiologists at various experience levels, to improve both acute and long-term patient outcomes, mitigate potential complications, and optimize hospitals’ operational and financial burdens. LuSeed has currently began its clinical phase, with so far highly promising results.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
LuSeed Vascular appoints Robert Stern to board of directors - NeuroNews International
LuSeed Vascular has nominated Robert Stern, a seasoned medical device executive and investor, as the vice chairman of its board of directors. Stern has served as an advisor to several medical device companies and has been a board member of multiple neurovascular-focused companies. LuSeed co-founders Nitzan Hirsh and Amir Arthur expressed their confidence in Sterns extensive background in medical entrepreneurship and M&A, particularly in the intervascular field. LuSeeds device, described as a revolutionary implant suitable for most aneurysms, is the first of its kind that does not have a marker protruding into the parent artery.
Management Changes
growth-positive
Sanara Ventures Announces Winners of Healthcare Startup Competition
Sanara Ventures Ltd., an Israel-based healthcare-focused early stage investment group and incubator backed by Teva Pharmaceutical Industries Ltd. and Koninklijke Philips NV, has announced the winners of its startup competition. LuSeed Vascular Ltd., a company developing an implant for treating aneurysms, won the medical device category. TuneFork, a company developing an audio personalization app intended to improve quality of life for people with hearing loss and elders, won the digital health category. Both companies will receive a seed investment of up to $1 million each, and mentoring.
Investment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $6.5M |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 3 |
| Investors | 4 |
Team Members
11
Employees: 11-50
Web & Social Links
| Website | luseed-vascular.com |
Locations
Derech Yitshak Rabin 1, Petah Tikva, Israel
Photos & Videos
1 item(s)
